Clinical Trials Directory

Trials / Completed

CompletedNCT05687201

Effect of Apolipoprotein E on the Prognosis of Patients With Intracerebral Hemorrhage

Effect of Apolipoprotein E4 on Perihematomal Edema and Short-term Prognosis in Patients With Intracerebral Hemorrhage

Status
Completed
Phase
Study type
Observational
Enrollment
330 (actual)
Sponsor
The Affiliated Hospital Of Guizhou Medical University · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

The purpose of this observational study was to compare perihematomal edema and short-term prognosis in patients with intracerebral hemorrhage carrying the APOE-ε3 and APOE-ε4 genes. The main questions it aims to answer are: * Exploring whether patients carrying the ApoE-ε4 gene have more perifocal perihematomal edema after intracerebral hemorrhage than patients with the ApoE-ε3 gene. * ApoEε4 gene has worse short-term prognosis than ApoEε3 gene in intracerebral hemorrhage patients. All the patients in this study received the same medications based on the guidelines for the management of hypertensive intracerebral hemorrhage.Some ICH patients were evaluated for Stereotactic minimally invasive surgery (sMIS) treatment by two experienced neurosurgeons.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTNon-enhanced CT scan、Nuclear Magnetic Resonance (MRI)Non-surgical patients were followed up by CT on days 1 and 5-7 after ICH, and by CT or MRI on day 5-7. Surgical patients were followed up by CT before surgery and then transferred to the operating room. The first postoperative follow-up CT scan was performed on the second day after surgery, and the second postoperative CT scan was performed on the third day after surgery. Some patients need a third or even a fourth CT follow-up after surgery. The CT scan can be repeated at any time if the patient has neurologic deterioration.

Timeline

Start date
2020-01-01
Primary completion
2023-12-01
Completion
2023-12-01
First posted
2023-01-18
Last updated
2024-08-09

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05687201. Inclusion in this directory is not an endorsement.